Aether Industries Ltd
Incorporated in 2013, Aether Industries Limited is a manufacturer of specialty chemicals. The company is sole Indian manufacturer for chemicals such as 4-(2-Methoxyethyl) Phenol (4MEP), and 3-Methoxy-2-Methylbenzoyl Chloride (MMBC), Thiophene-2-Ethanol (T2E), Ortho Tolyl Benzo Nitrile (OTBN), N-Octyl-D-Glucamine, Delta-Valerolactone, and Bifenthrin Alcohol.[1]
- Market Cap ₹ 11,035 Cr.
- Current Price ₹ 832
- High / Low ₹ 1,211 / 762
- Stock P/E 85.3
- Book Value ₹ 154
- Dividend Yield 0.00 %
- ROCE 18.4 %
- ROE 15.9 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 75.6% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 25.3%
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Debtor days have increased from 111 to 145 days.
- Working capital days have increased from 191 days to 269 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|
0 | 1 | 0 | 24 | 109 | 201 | 302 | 450 | 590 | 651 | 664 | |
1 | 3 | 1 | 22 | 85 | 154 | 230 | 338 | 422 | 465 | 483 | |
Operating Profit | -1 | -2 | -1 | 2 | 23 | 48 | 72 | 112 | 168 | 186 | 182 |
OPM % | -252% | -194% | 10% | 21% | 24% | 24% | 25% | 28% | 29% | 27% | |
3 | 4 | 1 | 0 | 0 | 2 | 2 | 4 | 7 | 17 | 25 | |
Interest | 1 | 1 | 0 | 1 | 9 | 11 | 9 | 11 | 13 | 5 | 6 |
Depreciation | 0 | 0 | 0 | 1 | 5 | 6 | 8 | 11 | 15 | 23 | 36 |
Profit before tax | 0 | 0 | 0 | 1 | 9 | 33 | 57 | 94 | 146 | 174 | 164 |
Tax % | 39% | 27% | 31% | 300% | 17% | 28% | 29% | 24% | 26% | 25% | |
0 | 0 | 0 | -1 | 8 | 23 | 40 | 71 | 109 | 130 | 125 | |
EPS in Rs | 0.14 | 0.12 | 0.11 | -1.27 | 9.08 | 27.27 | 46.68 | 70.43 | 9.67 | 10.47 | 9.59 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 43% |
3 Years: | 29% |
TTM: | 8% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 76% |
3 Years: | 48% |
TTM: | 9% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | -12% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 29% |
3 Years: | 25% |
Last Year: | 16% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 9 | 9 | 34 | 9 | 9 | 9 | 9 | 10 | 113 | 125 | 133 |
Reserves | 0 | 0 | 0 | -1 | 7 | 30 | 70 | 164 | 274 | 1,120 | 1,914 |
Preference Capital | 0 | 0 | 25 | 25 | 25 | 25 | 25 | 0 | 0 | 0 | |
40 | 35 | 28 | 86 | 101 | 101 | 147 | 211 | 291 | 16 | 17 | |
1 | 1 | 4 | 44 | 43 | 67 | 75 | 67 | 92 | 120 | 160 | |
Total Liabilities | 50 | 45 | 65 | 137 | 159 | 207 | 300 | 453 | 770 | 1,380 | 2,223 |
2 | 1 | 1 | 56 | 100 | 106 | 129 | 216 | 257 | 646 | 718 | |
CWIP | 7 | 20 | 42 | 40 | 2 | 1 | 17 | 0 | 58 | 37 | 86 |
Investments | 16 | 8 | 0 | 0 | 0 | 0 | 0 | 22 | 17 | 1 | 12 |
25 | 15 | 21 | 41 | 56 | 99 | 154 | 214 | 438 | 695 | 1,407 | |
Total Assets | 50 | 45 | 65 | 137 | 159 | 207 | 300 | 453 | 770 | 1,380 | 2,223 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
-1 | -3 | -6 | -9 | 6 | 23 | 18 | 23 | -5 | -7 | |
-33 | 2 | -14 | -48 | -11 | -13 | -48 | -77 | -151 | -348 | |
47 | -6 | 17 | 57 | 4 | -10 | 33 | 55 | 169 | 439 | |
Net Cash Flow | 13 | -8 | -3 | -1 | -0 | 0 | 2 | 2 | 12 | 84 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 94 | 4,358 | 167 | 88 | 87 | 76 | 88 | 101 | 145 | |
Inventory Days | 52 | 9,733 | 629 | 149 | 133 | 166 | 141 | 221 | 301 | |
Days Payable | 172 | 1,922 | 575 | 92 | 76 | 88 | 82 | 95 | 99 | |
Cash Conversion Cycle | -25 | 12,169 | 220 | 144 | 144 | 153 | 147 | 227 | 348 | |
Working Capital Days | 3,568 | 15,983 | 304 | 123 | 71 | 97 | 121 | 183 | 269 | |
ROCE % | -1% | -0% | 2% | 14% | 28% | 32% | 33% | 30% | 18% |
Documents
Announcements
- Board Meeting Intimation for Adoption And Approval Of The Audited Financial Results 2d
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
23 Apr - In accordance with Regulation 24A of the SEBI (LODR) Regulations, 2015, we herewith submit the Secretarial Compliance Report for the FY 2023-24, as annexed.
-
Announcement under Regulation 30 (LODR)-Credit Rating
12 Apr - In accordance with the Regulation 30 of the SEBI (LODR) Regulations, 2015, we herewith submit the credit rating, as annexed.
- Compliance Certificate Reg. 40(9) Of SEBI (LODR) Regulations, 2015 10 Apr
-
Announcement under Regulation 30 (LODR)-Press Release / Media Release
10 Apr - In connection with Regulation 30 of the SEBI (LODR) Regulations, 2015, we submit herewith the Press Release, as annexed.
Concalls
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT REC
-
Jul 2023Transcript PPT
-
Jun 2023Transcript PPT
-
May 2023TranscriptNotesPPT
-
Jan 2023Transcript PPT
-
Jan 2023TranscriptNotesPPT
-
Nov 2022Transcript PPT
-
Jul 2022Transcript PPT
-
Jun 2022Transcript PPT
Business Segments FY23